ANTX vs AOS · $32.0M cap vs P/E 19, rev $1.00B
AN2 Therapeutics Inc (ANTX) versus Smith AO Corporation (AOS) — a side-by-side from cached financials, not a winner call.
AN2 Therapeutics Inc (ANTX) is a biotechnology company listed on US.
Smith AO Corporation (AOS) is a specialty industrial machinery company listed on US.
ANTX does not have a complete income-statement cache yet.
Latest reported AOS revenue for 2026-06-30 was $1.00B. Net income was $124.9M. Revenue was up 6.2% from 2026-03-31 to 2026-06-30. AOS currently screens at market cap $9.73B and trailing P/E 19.1.
ANTX currently screens at market cap $32.0M. AOS currently screens at market cap $9.73B and trailing P/E 19.1.
Not investment advice. Open the ANTX and AOS stock pages for the full models.
Not investment advice.